Chimin Health Management Co., Ltd.

隶属于 double-dove group co., ltd.

The company was founded in 1996 and has a number of wholly-owned subsidiaries: Taizhou Jurui Plastic Technology Co., Ltd., Zhejiang Jimintang Pharmaceutical Trading Co., Ltd., Shanghai Jumin Biotechnology Co., Ltd., Spanish Linia Chemical Co., Ltd., and Baoaopule (Hainan) Biotechnology Co., Ltd. As a modern pharmaceutical listed company, Jimin is committed to the R&D, production, and sales of human drugs and medical devices. It has established long-term and stable strategic partnerships with American medical device giants and many domestic institutions of higher learning and scientific research institutions. It has 53 national patents and 7 registration certificates for pharmaceutical packaging materials. The company's main business includes three business segments: medical services, medical devices, and large infusions. The company's products mainly include three hospitals, Ao International Hospital, Ezhou Chengnan Hospital, and Ezhou Second Hospital, injection-puncture device series products, pre-filled catheter irrigator series products, in-vitro diagnostic products, non-PVC soft bag series products, plastic bottle series products, and vertical soft bag series products. Corporate honors: On December 31, 2014, Jimin's Type 5 graphic trademark was recognized as a famous trademark in Zhejiang Province by the Zhejiang Administration for Industry and Commerce, and on August 18, 2003, Jimin Pharmaceutical Company was rated as a “Zhejiang Famous Brand”.